iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Down 73.6% in June

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the recipient of a large drop in short interest in the month of June. As of June 30th, there was short interest totaling 3,425 shares, a drop of 73.6% from the June 15th total of 12,988 shares. Based on an average daily volume of 4,287 shares, the short-interest ratio is presently 0.8 days. Approximately 2.3% of the company’s shares are sold short.

iShares Neuroscience and Healthcare ETF Stock Down 3.1%

Shares of IBRN traded down $1.24 during trading hours on Friday, reaching $39.05. 6,859 shares of the company traded hands, compared to its average volume of 2,129. iShares Neuroscience and Healthcare ETF has a 12 month low of $22.41 and a 12 month high of $40.42. The company’s fifty day moving average price is $36.08 and its two-hundred day moving average price is $33.80. The company has a market capitalization of $5.86 million, a price-to-earnings ratio of 15.61 and a beta of 0.73.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.